Human immunoglobulin (Chengdu Rongsheng Pharmaceuticals)

人免疫球蛋白(成都蓉生药业)

Report date: 2024/12/03 11:06:49

Base Information

Drug NameHuman immunoglobulin (Chengdu Rongsheng Pharmaceuticals)
Drug Alias Name皮下注射人免疫球蛋白
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPrimary Immunodeficiency DiseasesHepatitisMeasles
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPrimary Immunodeficiency DiseasesHepatitisMeasles
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA01
Related LinksN/A